SK bioscience has led Korea’s vaccine industry with advanced R&D capabilities
and state-of-the-art manufacturing facilities.
The company has also earned global recognition for both the self development
and contract manufacturing of its COVID-19 vaccine.

SK bioscience is expanding its proprietary vaccine portfolio and enhancing its R&D
and manufacturing infrastructure, while actively entering new areas of biotechnology
and securing global production hubs—all in pursuit of safeguarding human health.

Driven by the passion of every employee, SK bioscience remains committed
to spreading hope across the globe—continuing our efforts each and every day.